|
US5114719A
(en)
*
|
1987-04-29 |
1992-05-19 |
Sabel Bernhard A |
Extended drug delivery of small, water-soluble molecules
|
|
US5156164A
(en)
*
|
1988-10-13 |
1992-10-20 |
Leveen Harry H |
Iodine contraceptive sponge
|
|
BE1002600A3
(fr)
*
|
1988-11-23 |
1991-04-09 |
Wildemeersch Dirk |
Dispositif intra-uterin perfectionne.
|
|
IE71202B1
(en)
*
|
1990-12-17 |
1997-02-12 |
Akzo Nv |
Progestagen-only contraceptive
|
|
WO1993017662A1
(en)
*
|
1992-03-02 |
1993-09-16 |
Daratech Pty. Ltd. |
Improved implants
|
|
EP0572932B1
(de)
*
|
1992-06-02 |
2000-09-13 |
C.R. Bard, Inc. |
Verfahren und Implantatvorrichtung für Langzeitwirkstoffabgabe
|
|
US5368588A
(en)
*
|
1993-02-26 |
1994-11-29 |
Bettinger; David S. |
Parenteral fluid medication reservoir pump
|
|
US5443461A
(en)
*
|
1993-08-31 |
1995-08-22 |
Alza Corporation |
Segmented device for simultaneous delivery of multiple beneficial agents
|
|
US5681817A
(en)
|
1994-02-04 |
1997-10-28 |
The Medical College Of Hampton Roads |
Treatment of ovarian estrogen dependent conditions
|
|
US5660848A
(en)
*
|
1994-11-02 |
1997-08-26 |
The Population Council, Center For Biomedical Research |
Subdermally implantable device
|
|
US5521166A
(en)
*
|
1994-12-19 |
1996-05-28 |
Ortho Pharmaceitical Corporation |
Antiprogestin cyclophasic hormonal regimen
|
|
DE19539361A1
(de)
*
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
|
|
US5733565A
(en)
*
|
1996-02-23 |
1998-03-31 |
The Population Council, Center For Biomedical Research |
Male contraceptive implant
|
|
CN1088993C
(zh)
*
|
1996-10-11 |
2002-08-14 |
上海市计划生育科学研究所 |
含孕二烯酮的长效皮下避孕埋植剂
|
|
US6203813B1
(en)
|
1997-01-13 |
2001-03-20 |
Lance L. Gooberman |
Pharmaceutical delivery device and method of preparation therefor
|
|
TW358031B
(en)
*
|
1997-04-11 |
1999-05-11 |
Akze Nobel N V |
Drug delivery system for 2 or more active substances
|
|
DE19744135C1
(de)
*
|
1997-09-29 |
1999-03-25 |
Schering Ag |
Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
|
|
EP1100669B1
(de)
|
1998-05-01 |
2005-12-21 |
Duramed Pharmaceuticals, Inc. |
Verfahren zur spritzgussherstellung von vorrichtungen mit kontrollierter wirkstofffreisetzung und damit hergestellte vorrichtung
|
|
US6117441A
(en)
*
|
1998-07-02 |
2000-09-12 |
The Population Council, Inc. |
Silicone core long term androgen delivery implant
|
|
WO2000003678A2
(en)
*
|
1998-07-17 |
2000-01-27 |
Pharmacia & Upjohn Company |
Subcutaneous medroxyprogesterone acetate for contraception
|
|
US6063395A
(en)
*
|
1998-11-12 |
2000-05-16 |
Leiras Oy |
Drug delivery device especially for the delivery of progestins and estrogens
|
|
US6117442A
(en)
*
|
1998-11-12 |
2000-09-12 |
Leiras Oy |
Drug delivery device, especially for the delivery of androgens
|
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
CA2267743C
(en)
*
|
1999-03-30 |
2011-07-26 |
Robert F. Casper |
Low dose estrogen interrupted hormone replacement therapy
|
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
ES2253423T3
(es)
*
|
2000-08-23 |
2006-06-01 |
Akzo Nobel N.V. |
Formulacion de un ester de testosterona para uso humano.
|
|
WO2004026111A2
(en)
|
2000-11-16 |
2004-04-01 |
Microspherix Llc |
Flexible and/or elastic brachytherapy seed or strand
|
|
DE60229375D1
(de)
|
2001-05-11 |
2008-11-27 |
Ortho Mcneil Janssen Pharm |
Immunmodulations-vorrichtung zur verwendung in tieren
|
|
DE60209734T2
(de)
|
2001-07-02 |
2006-08-31 |
Akzo Nobel N.V. |
Tetrahydrochinolin-derivate
|
|
EP1427390A1
(de)
*
|
2001-08-31 |
2004-06-16 |
Schering Oy |
System zur freisetzung von arzneimitteln
|
|
TWI228508B
(en)
|
2001-09-04 |
2005-03-01 |
Akzo Nobel Nv |
Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity
|
|
CA2457212C
(en)
|
2001-09-04 |
2011-02-15 |
Akzo Nobel Nv |
Glycine-substituted thieno [2,3-d]pyrimidines with combined lh and fsh agonistic activity
|
|
NZ534317A
(en)
*
|
2002-01-24 |
2006-06-30 |
Smart Drug Systems Inc |
Sustained release pharmaceutical composition carried in or on silicone support material
|
|
AU2003222273A1
(en)
*
|
2002-03-11 |
2003-09-29 |
Janssen Pharmaceutica N.V. |
Sulfatase inhibiting progestogen-only contraceptive regimens
|
|
TWI297685B
(en)
|
2002-04-04 |
2008-06-11 |
Organon Nv |
Non-steroidal progesterone receptor modulators
|
|
KR20100120243A
(ko)
*
|
2002-05-07 |
2010-11-12 |
피시비다 유에스 인코포레이티드 |
약물 전달 장치를 형성하는 공정
|
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
|
JP4668611B2
(ja)
*
|
2002-05-31 |
2011-04-13 |
タイタン ファーマシューティカルズ インコーポレイテッド |
ブプレノルフィンの持続放出のための埋め込み型ポリマー製装置
|
|
RS20050184A
(sr)
*
|
2002-08-28 |
2007-11-15 |
Robert Casper |
Režim zamene estrogena
|
|
US7795280B2
(en)
|
2002-11-07 |
2010-09-14 |
N.V. Organon |
Indoles useful in the treatment of androgen-receptor related diseases
|
|
TWI306855B
(en)
|
2002-12-20 |
2009-03-01 |
Organon Nv |
Tetrahydroquinoline derivatives
|
|
TWI322012B
(en)
|
2002-12-20 |
2010-03-21 |
Organon Nv |
Tetrahydroquinoline derivatives
|
|
ES2359977T3
(es)
*
|
2003-03-31 |
2011-05-30 |
Titan Pharmaceuticals, Inc. |
Dispositivo polimérico implantable para liberación sostenida de agonista de dopamina.
|
|
EP1620060B1
(de)
|
2003-04-29 |
2010-03-24 |
The General Hospital Corporation |
Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
|
|
TWI336627B
(en)
|
2003-05-23 |
2011-02-01 |
Organon Nv |
Drug delivery system,and use and manufacturing method thereof
|
|
AU2004247057A1
(en)
*
|
2003-05-30 |
2004-12-23 |
Titan Pharmaceuticals, Inc. |
Implantable polymeric device for sustained release of nalmefene
|
|
KR20060039867A
(ko)
*
|
2003-06-20 |
2006-05-09 |
바이럴 게노믹스, 인크. |
Hiv 치료를 위한 조성물 및 방법
|
|
JP2007517912A
(ja)
*
|
2004-01-13 |
2007-07-05 |
バソジェニックス ファーマシューティカルズ, インコーポレイテッド |
心脈管および腎臓の適応症のための制御放出cgrp送達組成物
|
|
JP2007517911A
(ja)
*
|
2004-01-13 |
2007-07-05 |
バソジェニックス ファーマシューティカルズ, インコーポレイテッド |
心臓血管の適応症および腎臓の適応症に対してcgrpを使用する方法
|
|
US20090023643A1
(en)
*
|
2004-01-13 |
2009-01-22 |
Vasogenix Pharmaceuticals, Inc. |
Methods For Treating Acute Myocardial Infarction By Administering Calcitonin Gene Related Peptide And Compositions Containing The Same
|
|
TWI434676B
(zh)
*
|
2004-03-19 |
2014-04-21 |
Merck Sharp & Dohme |
可用x射線看出之藥物遞送裝置
|
|
TW200531977A
(en)
|
2004-03-25 |
2005-10-01 |
Akzo Nobel Nv |
Progesterone receptor modulators
|
|
TW200602317A
(en)
|
2004-04-23 |
2006-01-16 |
Akzo Nobel Nv |
Novel androgens
|
|
SI1629844T1
(sl)
|
2004-07-13 |
2007-12-31 |
Bayer Schering Pharma Oy |
Sistem podaljšanega oddajanja s kontrolirano začetno dozo
|
|
CA2575988C
(en)
|
2004-08-04 |
2014-02-18 |
Brookwood Pharmaceuticals, Inc. |
Methods for manufacturing delivery devices and devices thereof
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
AU2006259368A1
(en)
|
2005-06-15 |
2006-12-28 |
Hydra Biosciences, Inc. |
Modulators of sperm hypermotility and uses thereof
|
|
EP1743638A1
(de)
|
2005-07-15 |
2007-01-17 |
Laboratorios Del Dr. Esteve, S.A. |
Pharmazeutische Formulierungen von substituierten Pyrazolinderivaten
|
|
JP5048773B2
(ja)
|
2006-08-09 |
2012-10-17 |
インターシア セラピューティクス,インコーポレイティド |
浸透圧式デリバリーシステム及びピストンアセンブリー
|
|
US7989442B2
(en)
|
2006-09-27 |
2011-08-02 |
N.V. Organon |
Progesterone receptor modulators
|
|
CN101209238B
(zh)
*
|
2006-12-27 |
2012-05-09 |
辽宁省计划生育科学研究院 |
含孕二烯酮的生物降解型长效皮下避孕埋植剂及其制备
|
|
AU2008244523B2
(en)
|
2007-04-23 |
2012-02-16 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
|
US8063037B2
(en)
|
2007-05-07 |
2011-11-22 |
N. V. Organon |
Progesterone receptor modulators
|
|
CN101130057B
(zh)
*
|
2007-07-06 |
2011-04-27 |
复旦大学 |
胸腺五肽长效植入剂及其制备方法
|
|
US8741329B2
(en)
|
2007-09-21 |
2014-06-03 |
Merck Sharp & Dohme B.V. |
Drug delivery system
|
|
EP2227252B1
(de)
|
2007-11-27 |
2012-07-25 |
Nira Hochman |
Adjuvans von Vaccinium macrocarpon
|
|
JP5502751B2
(ja)
|
2007-12-20 |
2014-05-28 |
エボニック コーポレイション |
低残留溶媒濃度を有する微粒子を調製するためのプロセス
|
|
DK2240155T3
(da)
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
|
|
SMT201700583T1
(it)
|
2009-09-28 |
2018-01-11 |
Intarcia Therapeutics Inc |
Instaurazione e/o terminazione rapida di erogazione di farmaci in modo sostanzialmente stazionario
|
|
JP2013515741A
(ja)
*
|
2009-12-23 |
2013-05-09 |
サイヴィーダ ユーエス,インコーポレイテッド |
持続放出性送達デバイス
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
US10028858B2
(en)
|
2011-07-11 |
2018-07-24 |
Medicines360 |
Intrauterine systems, IUD insertion devices, and related methods and kits therefor
|
|
AR089765A1
(es)
*
|
2012-01-23 |
2014-09-17 |
Bayer Oy |
Un sistema para el suministro de un farmaco
|
|
USD718435S1
(en)
|
2012-05-30 |
2014-11-25 |
Medicines360 |
Intrauterine insertion device
|
|
EP2953558B1
(de)
|
2013-02-06 |
2019-08-28 |
Sillender, Mark |
Embryonentransferkatheter
|
|
AU2014214537B2
(en)
|
2013-02-06 |
2019-01-03 |
Mark SILLENDER |
Therapeutic substance transfer catheter and method
|
|
US10413504B2
(en)
|
2013-12-11 |
2019-09-17 |
Merck Sharp & Dohme Corp. |
Intravaginal ring drug delivery system
|
|
US10596103B2
(en)
|
2013-12-11 |
2020-03-24 |
Merek Sharp & Dohme B.V. |
Drug delivery system for delivery of anti-virals
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
WO2016149561A1
(en)
*
|
2015-03-17 |
2016-09-22 |
Oak Crest Institute Of Science |
Subdermal implants for the sustained delivery of water-soluble drugs
|
|
US10925639B2
(en)
|
2015-06-03 |
2021-02-23 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
|
KR20240037175A
(ko)
|
2016-05-16 |
2024-03-21 |
인타르시아 세라퓨틱스 인코포레이티드 |
글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
WO2018064556A1
(en)
|
2016-09-29 |
2018-04-05 |
Gesea Biosciences Inc. |
Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
|
|
MX2019008006A
(es)
|
2017-01-03 |
2019-08-29 |
Intarcia Therapeutics Inc |
Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.
|
|
US11571328B2
(en)
|
2018-04-09 |
2023-02-07 |
Medicines360 |
IUD insertion devices
|
|
CN119236191A
(zh)
|
2018-05-24 |
2025-01-03 |
塞拉尼斯伊娃高性能聚合物公司 |
用于持续释放大分子药物化合物的可植入器件
|
|
MX2020012458A
(es)
|
2018-05-24 |
2021-04-28 |
Celanese Eva Performance Polymers Llc |
Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
|
|
US11689849B2
(en)
|
2018-05-24 |
2023-06-27 |
Nureva, Inc. |
Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
|
|
US20200261258A1
(en)
|
2019-02-19 |
2020-08-20 |
Medicines360 |
Devices, systems, methods and kits for insertion and removal of iuds
|
|
BR102020007749A2
(pt)
|
2020-04-17 |
2021-11-03 |
Edson Luiz Peracchi |
Implante subcutâneo reabsorvível de longa duração com liberação controlada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da endometriose
|
|
BR102020010923A2
(pt)
|
2020-05-29 |
2021-12-14 |
Luiz Peracchi Edson |
Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da insuficiência adrenal crônica ou hipocortisolismo
|
|
BR102020013862A2
(pt)
|
2020-07-07 |
2022-01-18 |
Edson Luiz Peracchi |
Implante subcutâneo reabsorvível de longa duração com liberação sustentada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da doença de parkinson
|
|
WO2022204771A1
(pt)
|
2021-03-29 |
2022-10-06 |
Edson Luiz Peracchi |
Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento do hipotireoidismo e processo
|
|
JP2024515220A
(ja)
|
2021-04-26 |
2024-04-05 |
セラニーズ・イーブイエイ・パフォーマンス・ポリマーズ・エルエルシー |
高分子薬剤化合物の持続放出用の埋め込み型デバイス
|
|
CN113209050A
(zh)
*
|
2021-05-14 |
2021-08-06 |
浙江恒冀制药有限责任公司 |
基于生物相容性聚合物的长效体内皮埋或内植缓释制剂
|
|
US20230233455A1
(en)
*
|
2022-01-24 |
2023-07-27 |
Celanese Eva Performance Polymers Llc |
Method for Prohibiting and/or Treating an Eye Condition
|
|
US12544256B2
(en)
|
2022-09-16 |
2026-02-10 |
Medicines360 |
IUD removal devices, and related methods and kits
|
|
WO2024184356A1
(en)
*
|
2023-03-06 |
2024-09-12 |
Institut National de la Santé et de la Recherche Médicale |
Miniaturized implants for the inner ear
|
|
GB202401392D0
(en)
|
2024-02-02 |
2024-03-20 |
Imphatec Ltd |
Implant for delivery of a drug
|
|
WO2025174767A1
(en)
*
|
2024-02-13 |
2025-08-21 |
Biraj Investments, Llc |
Highly loaded implantable devices with high tensile strength for drug delivery
|